Filter
192
Filtered Results: 192
Text search:
Carlier,
Y.
Featured
Recommendations
28
New Publications
43
Language
Document type
No document type
102
Studies & Reports
36
Guidelines
33
Manuals
15
Strategic & Response Plan
2
Fact sheets
2
Training Material
1
Situation Updates
1
Countries / Regions
India
12
Latin America and the Carribbean
10
Kenya
5
Brazil
5
Africa
5
Nepal
4
Zambia
4
Malawi
4
Mozambique
4
West and Central Africa
4
Nigeria
3
Senegal
3
Ethiopia
3
Uganda
3
Zimbabwe
3
Haiti
3
Philippines
3
Indonesia
3
South Africa
3
Myanmar / Burma
3
East and Southern Africa
3
Western and Central Europe
3
Global
3
Guinea
2
Burkina Faso
2
Morocco
2
Ghana
2
Lebanon
2
Tanzania
2
Argentina
2
North Macedonia
2
Colombia
2
Bolivia
2
Mexico
2
Georgia
2
Portugal
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
USA
1
Saudi Arabia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Germany
1
Turkey
1
Syria
1
Thailand
1
Bangladesh
1
Sudan
1
Namibia
1
Hungary
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Asia
1
Albania
1
Russia
1
Iran
1
Kyrgyzstan
1
Jamaica
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
72
Clinical Guidelines
31
Public Health
19
Key Resources
9
Women & Child Health
5
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
COVID-19
18
NTDs
17
Planetary Health
10
Ebola
8
AMR
7
Rapid Response
6
Mental Health
6
Pharmacy
6
Natural Hazards
5
HIV
5
TB
4
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Polio
2
Refugee
2
NCDs
2
Cholera
1
Specific Hazards
1
Productive and Inclusive Cities for an Emerging Democratic Republic of Congo
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
Cette évaluation a trois principaux objectifs :
1 - Evaluer la qualité des données collectées par le système LP depuis septembre 2010 à septembre 2012.
2 - En fonction de la qualité de ces données, appuyer l’équipe terrain, basée principalement à Diapaga, dans l’analyse statistique ...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
August 2020.
In December 2018, the President launched the UHC pilot covering four strategically selected counties-Isiolo, Kisumu, Machakos and Nyeri. It isplanned that by the year 2022, all persons in Kenya will be able to use the essential services they need for their health...
The Impacts of Climate Change on Human Health
in the United States: A Scientific Assessment
Climate change is a significant threat to the health of the American people. This scientific assessment examines how climate change is already affecting human health and the changes that may occur in the fu...
Lancet Planet Health 2022;6: e760–68
The emergence of COVID-19 has drawn the attention of health researchers sharply back to the role that food systems can play in generating human disease burden. But emerging pandemic threats are just one dimension of the complex relationship between agriculture...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
The article explores the underlying factors influencing unhealthy diets and sedentary lifestyles among adolescents in Kilifi County, Kenya. Using a qualitative approach, the study involved interviews and focus group discussions with adolescents, stakeholders, and young adults. Key findings include a...
Doc. No.: INS/GDL/001-(Annexes)
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and to repeal the Food
(Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978 and to provide for related matters.
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
